Investor Relations

Fusion Antibodies is a CRO that offers a range of antibody engineering services for all stages of therapeutic and diagnostic antibody development.

Latest News

Grant of options
19 October 2021
New contract win
07 October 2021
Block Admission Application, Exercise of Options and Total Voting Rights
27 September 2021

View Share Price

Share Price

GBp

updated every 15 minutes

Read more about us

Fusion Antibodies Company Profile

Read More »

View Investor Videos

Investor Videos

Watch latest video »

Sign up for Investor Alerts

Investor Alert

Sign up for Investor Alerts »